MedTrace Logo

Nutraceutical Supplement in the Management of Hypertension

NCT02663479 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-03-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cardiopressin

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Thorne HealthTech, Inc

    lead INDUSTRY

Principal Investigators

  • Mark Houston, MD, MS, MSc · Hypertension Institute

  • Bodi Zhang, MD, MPH, PhD · Thorne Research

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-08-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663479 on ClinicalTrials.gov